All articles by Anne-Charlotte Ackermann

Brukinsa: launch sequence of first Chinese cancer drug to roll out internationally

Two years after it became the first innovative Chinese-developed cancer medicine to be approved and launched in the United States,…
2021: a record year for orphan therapies

2021 has been a record year for orphan drugs, with subsequent brain-racking at stake for payers willing to provide access…
Value in healthcare: Insights from ISPOR

I am just back from beautiful Glasgow where this week you could see Roger Federer play in a kilt and…
Budget impact in France: A new key to market access

France is confirming its transition from a pricing model that is mainly based on clinical benefit towards a more economically-driven…

Sections